Target intelligence / Profile preview

Crumbs homolog 3 pseudogene

Molecular classification
Other
01

Overview

Crumbs homolog 3 pseudogene (ENSG00000218617) is a genomic sequence similar to the functional CRB3 gene, which encodes an essential transmembrane protein involved in epithelial cell polarity, but this pseudogene does not encode a functional protein. As a pseudogene, it is not considered a therapeutic target, does not participate in cell signaling, disease pathways, or drug interactions. Its presence primarily reflects the history of gene duplication or mutation, without known direct biological or medical relevance[2][6].

Other names
crumbs homolog 3 pseudogeneENSG00000218617

Beyond the preview

Go deeper on Crumbs homolog 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crumbs homolog 3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call